Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$39.55 – $153.47
91% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $291.13B | $296.00B | $323.46B | $401.14B | $417.55B | $370.51B | $369.44B | $418.82B |
| Cost of revenue | $232.81B | $227.84B | $238.01B | $281.06B | $290.03B | $268.04B | $256.11B | $290.22B |
| Gross profit | $58.32B | $68.15B | $85.45B | $120.08B | $127.52B | $102.47B | $113.33B | $128.60B |
| Gross margin | 20.0% | 23.0% | 26.4% | 29.9% | 30.5% | 27.7% | 30.7% | 30.7% |
| R&D | $14.75B | $16.20B | $16.84B | $15.73B | $19.68B | $20.23B | $183.0M | $0 |
| Operating income | $10.14B | $19.68B | $38.63B | $70.82B | $72.36B | $47.57B | $47.62B | $58.53B |
| EBITDA | $34.62B | $41.94B | $67.84B | $112.34B | $127.28B | $94.18B | $106.81B | $125.18B |
| Net income | $3.31B | $11.33B | $25.70B | $41.23B | $52.19B | $31.49B | $33.70B | $64.11B |
| Net margin | 1.1% | 3.8% | 7.9% | 10.3% | 12.5% | 8.5% | 9.1% | 15.3% |
| EPS (diluted) | 11.83 | 40.53 | 183.94 | 147.68 | 186.87 | 112.37 | 113.10 | 215.70 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $518.1B | $248.55 | $209.94–$277.10 | 1 |
| 2028 | $648.6B | $386.19 | $326.20–$430.55 | 1 |
| 2029 | $799.3B | $558.75 | $471.95–$622.92 | 1 |
| 2030 | $924.2B | $667.74 | $564.02–$744.43 | 1 |
Forward consensus · source: Financial Modeling Prep
IBIDEN CO LTD ORD
No one on the platform currently holds IBIDF.
No tracked institution reports a position in IBIDF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $20.0000 | |
| 2026-09-30 | $15.0000 | |
| 2026-03-31 | $15.0000 | 2026-06-05 |
| 2025-09-30 | $10.0000 | 2025-11-25 |
| 2025-09-30 | $20.0000 | 2025-11-25 |
| 2025-03-31 | $20.0000 | 2025-06-06 |
| 2024-09-30 | $20.0000 | 2024-11-25 |
| 2024-03-28 | $20.0000 | 2024-05-30 |
| 2023-09-29 | $20.0000 | 2023-11-27 |
No one on the platform has traded IBIDF yet.
| +8.42% |
| $8.1B |
| — |
| OCLCFOracle Corporation Japan | $59.90 | +0.00% | $7.7B | — |
| SNPTFSunny Optical Technology (Group) Company Limited | $9.60 | +0.00% | $10.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 1.3× earnings vs its 0.3× historical median P/E.
Fair value ≈ $39.79 · price $143.00 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.